These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1349783)
1. [The characteristics of the anxiolytic action of benzodiazepine and non-benzodiazepine tranquilizers in different tests of anxiety]. Talalaenko AN; Abramets II; Stakhovskiĭ IuV; Shekhovtsov AA; Shevchenko SL; Chernikov AV Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):144-51. PubMed ID: 1349783 [TBL] [Abstract][Full Text] [Related]
2. [The neurochemical profile of the septal nucleus accumbens in the anxiolytic action of tranquilizers on different models of anxiety]. Talalaenko AN; Panfilov VIu; Vozdigan SA; Pokramovich AI; Markova OP; Okhrimenko SV Eksp Klin Farmakol; 1997; 60(4):7-9. PubMed ID: 9376765 [TBL] [Abstract][Full Text] [Related]
3. [The neurochemical mechanisms of the central amygdaloid nucleus and the anxiolytic action of tranquilizers in different models of anxiety states]. Talalaenko AN; Krivobok GK; Babiĭ IuV; Bogdanov VA; Perch NN Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(6):1116-23. PubMed ID: 7879435 [TBL] [Abstract][Full Text] [Related]
4. [The neurochemical profile of the caudate nucleus in the anxiolytic action of benzodiazepine and nonbenzodiazepine tranquilizers on different models of anxiety]. Talalaenko AN; Gordienko DV; Markova OP Eksp Klin Farmakol; 2000; 63(1):14-8. PubMed ID: 10763103 [TBL] [Abstract][Full Text] [Related]
5. [A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction]. Talalaenko AN Farmakol Toksikol; 1989; 52(6):26-9. PubMed ID: 2576232 [TBL] [Abstract][Full Text] [Related]
6. [The neurochemical profile of the dorsal hippocampus and the antiaversive effects of anxiolytics in different models of anxiety in rats]. Talalaenko AN Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(3):621-6. PubMed ID: 8103252 [TBL] [Abstract][Full Text] [Related]
7. [Neurochemical features of the ventral pallidum in realization of the antiaversive effects of anxiolytics in different models of anxiety]. Talalaenko AN; Pankrat'ev DV; Bulgakova NP Eksp Klin Farmakol; 2006; 69(1):6-11. PubMed ID: 16579051 [TBL] [Abstract][Full Text] [Related]
8. [The mechanisms of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives, serotonin agonists]. Talalaenko AN; Kharin NA Eksp Klin Farmakol; 1993; 56(2):11-3. PubMed ID: 8102289 [TBL] [Abstract][Full Text] [Related]
9. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice. dos Reis LM; Canto-de-Souza A Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039 [TBL] [Abstract][Full Text] [Related]
10. [Effect of tranquilizers on the interaction processes of positive and negative reinforcement systems]. Kiseleva OV Farmakol Toksikol; 1979; 42(4):346-8. PubMed ID: 38993 [TBL] [Abstract][Full Text] [Related]
11. [Neurochemical analysis of the amygdala basolateral nucleus of rats during anxiety tests]. Talalaenko AN; Babiĭ IuV; Perch NN; Vozdvigin SA; Panfilov VIu Ross Fiziol Zh Im I M Sechenova; 1997 Mar; 83(3):88-94. PubMed ID: 12436687 [TBL] [Abstract][Full Text] [Related]
12. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats]. Kozlovskiĭ VL Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709 [TBL] [Abstract][Full Text] [Related]
13. [The functional role of monoaminergic and amino acid-ergic mechanisms of the locus coeruleus in anxiety from different aversive origins]. Talalaenko AN; Stakhovskiĭ IuV; Bogdanov BA; Babiĭ IuV; Perch NN Biull Eksp Biol Med; 1993 Jun; 115(6):634-6. PubMed ID: 8104050 [TBL] [Abstract][Full Text] [Related]
14. [Monoaminergic and aminoacidergic mechanisms of the posterior hypothalamus in realization of the antiaversive effects of anxiosedative and anxioselective agents in various anxiety models]. Talalaenko AN; Pankrat'ev DV; Goncharenko NV Eksp Klin Farmakol; 2002; 65(5):22-6. PubMed ID: 12596508 [TBL] [Abstract][Full Text] [Related]
15. [The nootropic and anxiolytic properties of different doses of piracetam]. Voronina TA; Molodavkin GM; Borlikova GG; Ostrovskaia RU; Tushmalova NA; Naznamov GG Eksp Klin Farmakol; 2000; 63(2):9-11. PubMed ID: 10834086 [TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like effects and safety profile of a tryptic hydrolysate from bovine alpha s1-casein in rats. Messaoudi M; Lalonde R; Schroeder H; Desor D Fundam Clin Pharmacol; 2009 Jun; 23(3):323-30. PubMed ID: 19453759 [TBL] [Abstract][Full Text] [Related]
17. [The effect of calcium channel blockers on animal behavior in tests to study their anxiolytic activity]. Kozlovskiĭ VL; Prakh'e IV Eksp Klin Farmakol; 1995; 58(1):18-20. PubMed ID: 7787686 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the action of tranquilizers on reinforcement systems]. Marusov IV Farmakol Toksikol; 1979; 42(3):203-8. PubMed ID: 36295 [TBL] [Abstract][Full Text] [Related]
20. [Dependence of the strength of anxiolytic effect of tranquilizers on the level of anxiety in a conflict situation]. Molodavkin GM; Voronina TA Biull Eksp Biol Med; 1996 Jan; 121(1):63-6. PubMed ID: 8680009 [No Abstract] [Full Text] [Related] [Next] [New Search]